Accumulated environmental risks have substantial impact on schizophrenia

By Laura Cowen, medwireNews Reporter

Accumulation of environmental risk factors has a “huge” effect on age at schizophrenia onset, German researchers report.

They found that individuals with four or more environmental risk factors develop the disease approximately 8 years earlier than those not exposed to well-studied schizophrenia risk factors, such as perinatal brain insults, cannabis use, neurotrauma, psychotrauma, urbanicity and migration.

By contrast, polygenic risk scores generated using comprehensive genome-wide association study data had no detectable effects on important schizophrenia phenotypes, namely age at disease and prodrome onset, symptom severity, cognitive function, employment and hospital admissions.

This indicates that “schizophrenia risk score-based analyses might not be optimised for study of association with disease-relevant phenotypes”, say the researchers.

The study included 750 men with schizophrenia or schizoaffective disorder from the Göttingen Research Association for Schizophrenia dataset.

Hannelore Ehrenreich and colleagues, from the Max Planck Institute of Experimental Medicine in Göttingen, first looked at whether exposure to individual environmental risk factors up to the age of 18 years, which they consider to be the most vulnerable time of brain development, was associated with measures of disease severity and socioeconomic functioning.

They report in The Lancet Psychiatry that perinatal complications, neurotrauma and cannabis use (ranging from any consumption up to regular use) were all significantly associated with younger age at disease onset and prodrome start.

Perinatal complications and cannabis use were associated with increased hospital admissions, while psychotrauma, cannabis use and migration were linked to fewer years of education. There was also a tendency for neurotrauma, urbanicity and cannabis use to be associated with fewer years in education.

However, the most striking findings were observed when the team compared patients without risk factor exposure to those with one to four or more environmental risks, with each additional risk factor worsening the outcome.

Schizophrenia symptoms appeared 8 years earlier in patients with four or more risk factors than in those with none, while prodrome appeared 9 years earlier. And having four or more risk factors was associated with 3 years less time spent in education, 39.5% more unemployment and 1.2 more hospital admissions, on average, when compared with having no risk factors.

Notably, cannabis use alone explained 10.2% of the variance in age at disease onset, compared with 4.7% explained by all other environmental risks together.

Since cannabis use is a preventable risk factor, “[t]his result calls for public education that targets prevention”, say they researchers, particularly as “age at onset of schizophrenia is a crucial determinant of an affected individual's fate and the total socioeconomic cost of the illness”.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Liver X receptor beta offers new hope in treating depression and anxiety